TEC 与 CD8? T 细胞互作可提升放疗疗效 ... 而且，SELP 高表达的患者，其局部无复发生存期（Local Recurrence - Free Survival，LRFS）、总生存期（Overall Survival，OS）和无进展生存期（Progression - Free Survival，PFS）都显著改善。经过多因素分析，确定了 SELP 高表达是宫颈癌 ...

Patients living with severe melanoma who had increased levels of suppressor, regulatory CD8 + T cells had worse survival outcomes. The study is published in the journal Nature Immunology.

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Once acquired infection persists for life requiring continuous life long cellular immunity (CD8 memory T cell and IFNγ dependent) for host survival. Development of this response relies on both ...

Candel Therapeutics (CADL) announced final overall survival data from the completed randomized controlled phase 2 clinical trial of CAN-2409 ...

Early data shows potent and selective CD8+ T cell activation without substantial ... 1 American Cancer Society. Lung Cancer Survival Rates. 2 Paz-Ares L, Chen Y, Reinmuth N, et al.

Due to the ongoing shortage of BCG, gemcitabine has been increasingly used for first-line NMIBC therapy. N-803’s ability to activate natural killer and CD8+ T cells, thus the innate immune system, to ...